GlassScriptPhysician profile
Thomas J Willis
NPI 1487896866
$387.87
in general payments reported to CMS, 2019-2025
10 companies · $116 in 2025
The $116 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $31.07 · 2023: $43.33 · 2024: $91.74 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trevena, INC. | $105.86 | 2021 | |
| Stryker Corporation | $72.53 | 2025 | Clottriever Bold Catheter |
| Mindray Ds USA, INC. | $43.33 | 2023 | A7 Anesthesia System |
| Abbott Laboratories | $36.00 | 2024 | Dragonfly Opstar |
| Avanos Medical | $31.07 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $24.06 | 2025 | Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.09 | 2024 | Lifevest |
| Solventum Corporation | $19.61 | 2024 | Spoton |
| Becton, Dickinson and Company | $19.28 | 2025 | Hemosphere |
| Biosense Webster, INC. | $14.04 | 2024 | Qdot Micro Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.